* Clover Health Investments Corp CLOV.OQ reported a
quarterly
adjusted loss of 14 cents per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -17 cents. The mean expectation of
three analysts for the quarter was for a loss of 14 cents per
share. Wall Street expected results to range from -18 cents
to -10 cents per share.
* Revenue fell 43.2% to $510.25 million from a year ago;
analysts
expected $480.26 million.
* Clover Health Investments Corp's reported EPS for the
quarter
was a loss of 14 cents.
* The company reported a quarterly loss of $70.47 million.
* Clover Health Investments Corp shares had fallen by 17.2%
this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the managed
healthcare
peer group is also "hold"
Wall Street's median 12-month price target for Clover Health
Investments Corp is $1.38
This summary was machine generated from LSEG data March 12 at
09:00 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.14 -0.14 Met
Sep. 30 2023 -0.11 -0.09 Beat
Jun. 30 2023 -0.15 -0.06 Beat
Mar. 31 2023 -0.18 -0.15 Beat